Grossman Adam S sold ADMA
February 17, 2026 · Form 4 insider transaction
Grossman Adam S sold 15,000 shares of ADMA Biologics, Inc. at $16.08 per share, a transaction worth $241.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$16.08
Total value
$241.2K
InsiderGrossman Adam S
RoleOfficer, Director
CompanyADMA Biologics, Inc. (ADMA)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 17, 2026
Filing dateFebruary 17, 2026
Shares owned after2,290,379
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025.; The price reported in Column 4 is the price at which the shares were sold.